Articles related to OBESITY/WEIGHT MANAGEMENT

Patients on GLP-1 medications may experience notable changes in breast morphology, such as decreased volume and increased sagging. Medical experts recommend supportive measures and a stable weight before considering surgical interventions.

Ozempic, commonly used off-label for weight management, can cause significant facial side effects, termed “Ozempic face,” marked by increased wrinkling and loss of skin elasticity.

Brazzein, now FDA-approved, emerges as a zero-calorie sweetener potentially safe for diabetic and obese populations, requiring further study to validate its health impacts.

Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.

This study highlights the role of avocados in enhancing diet quality and vegetable intake among adults with obesity, with no associated weight gain, suggesting a viable strategy for dietary improvement.

Semaglutide demonstrated a significant reduction in symptoms and weight among heart failure patients with diabetes, highlighted by a 7.3-point greater improvement in the Kansas City Cardiomyopathy Questionnaire clinical summary score compared to placebo.